Press "Enter" to skip to content

This Favorable Sign Appears On Biomarin Pharmaceutical's Chart

If history is any guide, there may be good fortune ahead for shares of Biomarin Pharmaceutical (NASDAQ:BMRN). A so-called “golden cross” has formed on its chart and, not surprisingly, this could be bullish for the stock.

What To Know: Many traders use moving average crossover systems to make their decisions.

When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending higher. If the short-term average price crosses below the long-term average price, it means the trend is lower.

Why It’s Important: The 50-day and the 200-day simple moving averages are commonly used.

The golden cross occurs when the 50-day crosses above the 200-day. This could mean the long-term trend is changing.

That just happened with Biomarin Pharmaceutical, which is trading around $89.57 at publication time.


Remember: Seasoned investors don’t blindly trade Golden Crosses.

Instead, they use it as a signal to start looking for long positions based on other factors, like price levels and company fundamentals & events.

For seasoned investors, this is just a sign that it might be time to start considering possible long positions.

With that in mind, take a look at Biomarin Pharmaceutical’s past and upcoming earnings expectations:

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.25 -0.11 -0.10 -0.19
EPS Actual -0.20 0.07 0.09 0.12
Revenue Estimate 435.32M 448.79M 446.45M 440.23M
Revenue Actual 408.74M 501.69M 486.03M 452.12M

Also consider this overview of Biomarin Pharmaceutical analyst ratings:


Do you use the Golden Cross signal in your trading or investing? Share this article with a friend if you found it helpful!

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

This post was originally published on this site

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *